Weighted Gene Co-Expression Network Analysis Identifies a Functional Guild and Metabolite Cluster Mediating the Relationship between Mucosal Inflammation and Adherence to the Mediterranean Diet in Ulcerative Colitis
- PMID: 37108484
- PMCID: PMC10138710
- DOI: 10.3390/ijms24087323
Weighted Gene Co-Expression Network Analysis Identifies a Functional Guild and Metabolite Cluster Mediating the Relationship between Mucosal Inflammation and Adherence to the Mediterranean Diet in Ulcerative Colitis
Abstract
Diet influences the pathogenesis and clinical course of inflammatory bowel disease (IBD). The Mediterranean diet (MD) is linked to reductions in inflammatory biomarkers and alterations in microbial taxa and metabolites associated with health. We aimed to identify features of the gut microbiome that mediate the relationship between the MD and fecal calprotectin (FCP) in ulcerative colitis (UC). Weighted gene co-expression network analysis (WGCNA) was used to identify modules of co-abundant microbial taxa and metabolites correlated with the MD and FCP. The features considered were gut microbial taxa, serum metabolites, dietary components, short-chain fatty acid and bile acid profiles in participants that experienced an increase (n = 13) or decrease in FCP (n = 16) over eight weeks. WGCNA revealed ten modules containing sixteen key features that acted as key mediators between the MD and FCP. Three taxa (Faecalibacterium prausnitzii, Dorea longicatena, Roseburia inulinivorans) and a cluster of four metabolites (benzyl alcohol, 3-hydroxyphenylacetate, 3-4-hydroxyphenylacetate and phenylacetate) demonstrated a strong mediating effect (ACME: -1.23, p = 0.004). This study identified a novel association between diet, inflammation and the gut microbiome, providing new insights into the underlying mechanisms of how a MD may influence IBD. See clinicaltrials.gov (NCT04474561).
Keywords: diet; inflammatory bowel disease; metabolomics; microbiome; ulcerative colitis; weighted gene co-expression analysis (WGCNA).
Conflict of interest statement
R.P.: Consultant, advisor, and speaker for Abbott, AbbVie, Alimentiv (formerly Robarts), Amgen, Arena Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol-Myers Squibb, Celgene, Celltrion, Cosmos Pharmaceuticals, Eisai, Elan, Eli Lilly, Ferring, Galapagos, Fresenius Kabi, Genentech, Gilead Sciences, Glaxo-Smith Kline, JAMP Bio, Janssen, Merck, Mylan, Novartis, Oppilan Pharma, Organon, Pandion Pharma, Pendopharm, Pfizer, Progenity, Protagonist Therapeutics, Roche, Sandoz, Satisfai Health, Shire, Sublimity Therapeutics, Takeda Pharmaceuticals, Theravance Biopharma, Trellus, Viatris, UCB. The remaining authors have no conflicts of interest to declare.
Figures








Similar articles
-
Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.J Dig Dis. 2019 Sep;20(9):447-459. doi: 10.1111/1751-2980.12795. Epub 2019 Aug 1. J Dig Dis. 2019. PMID: 31240835
-
Effectiveness of Mediterranean Diet's Adherence in children with Inflammatory Bowel Diseases.Nutrients. 2020 Oct 20;12(10):3206. doi: 10.3390/nu12103206. Nutrients. 2020. PMID: 33092159 Free PMC article.
-
Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.Trials. 2020 Jun 23;21(1):565. doi: 10.1186/s13063-020-04523-8. Trials. 2020. PMID: 32576228 Free PMC article.
-
From Evidence to Practice: A Narrative Framework for Integrating the Mediterranean Diet into Inflammatory Bowel Disease Management.Nutrients. 2025 Jan 28;17(3):470. doi: 10.3390/nu17030470. Nutrients. 2025. PMID: 39940329 Free PMC article. Review.
-
Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.Gastroenterology. 2020 Mar;158(4):930-946.e1. doi: 10.1053/j.gastro.2019.11.294. Epub 2019 Dec 5. Gastroenterology. 2020. PMID: 31812509
Cited by
-
Biomarkers of Intestinal Permeability Are Influenced by Diet in Patients with Ulcerative Colitis-An Exploratory Study.Diagnostics (Basel). 2024 Nov 22;14(23):2629. doi: 10.3390/diagnostics14232629. Diagnostics (Basel). 2024. PMID: 39682537 Free PMC article.
-
Efficacy of Whole-Food Based Anti-inflammatory Dietary Interventions in the Management of Ulcerative Colitis: A Systematic Review and Meta-Analysis.Dig Dis Sci. 2025 Aug 12. doi: 10.1007/s10620-025-09332-0. Online ahead of print. Dig Dis Sci. 2025. PMID: 40797000 Review.
-
Ultra-Processed Foods: A Narrative Review of the Impact on the Human Gut Microbiome and Variations in Classification Methods.Nutrients. 2024 Jun 1;16(11):1738. doi: 10.3390/nu16111738. Nutrients. 2024. PMID: 38892671 Free PMC article. Review.
-
Obesity-associated inflammation countered by a Mediterranean diet: the role of gut-derived metabolites.Front Nutr. 2024 Jun 24;11:1392666. doi: 10.3389/fnut.2024.1392666. eCollection 2024. Front Nutr. 2024. PMID: 38978699 Free PMC article. Review.
-
Reduced Sulfur Diet Reshapes the Microbiome and Metabolome in Mild-Moderate Ulcerative Colitis.Int J Mol Sci. 2025 May 11;26(10):4596. doi: 10.3390/ijms26104596. Int J Mol Sci. 2025. PMID: 40429741 Free PMC article.
References
-
- Singh S., George J., Boland B.S., Casteele N.V., Sandborn W.J. Primary Non-Response to Tumor Necrosis Factor Antagonists is Associated with Inferior Response to Second-line Biologics in Patients with Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. J. Crohn’s Colitis. 2018;12:635–643. doi: 10.1093/ecco-jcc/jjy004. - DOI - PMC - PubMed
-
- Limketkai B.N., Godoy-Brewer G., Parian A.M., Noorian S., Krishna M., Shah N.D., White J., Mullin G.E. Dietary Interventions for the Treatment of Inflammatory Bowel Diseases: An Updated Systematic Review and Meta-analysis. Clin. Gastroenterol. Hepatol. 2023 doi: 10.1016/j.cgh.2022.11.026. - DOI - PubMed
MeSH terms
Substances
Associated data
LinkOut - more resources
Full Text Sources
Medical